TABLE 3.
Alterations in serum cytokine levels during infectious mononucleosis
| Cytokine | Status during infectious mononucleosis | Possible impact on clinical pathogenesis (in terms of known function) | Reference(s) |
|---|---|---|---|
| IFN-γ | Elevated | Type II interferon, produced by NK cells and Th1 and CD8 T cells; broad immunostimulatory effects; important for control of chronic infection; likely inhibits viral replication and reactivation | 24, 39, 91, 125, 180, 216 |
| Neopterin | Elevated | A pteridine compound released from macrophages/monocytes stimulated by IFN-γ | 24, 125, 180 |
| IFN-α | Not reproducibly detected | Type I interferon, produced by monocytes and plasmacytoid dendritic cells; broad antiviral and immunostimulatory effects; important for control of acute infection | 91, 125, 159, 216 |
| IL-6 | Elevated | Inflammatory cytokine produced by T cells and macrophages; mediator of fever and acute-phase response; promotes B-cell maturation | 91, 125, 180, 218 |
| TNF-α | Elevated | Inflammatory cytokine produced mainly by macrophages; activates macrophages, stimulates acute-phase response, and can cause liver dysfunction and fever | 24, 218 |
| IL-12 | Elevated | Cytokine produced by dendritic cells; promotes differentiation of Th1 CD4 and CD8 T cells; enhances NK and CTL cytotoxicity | 39, 216 |
| IL-2 | Occasionally elevated | Produced by activated T cells; growth factor for regulatory T cells | 24, 39, 91, 216, 218 |
| IL-10 | Elevated | Immunosuppressive cytokine produced by monocytes and T cells; in combination with viral IL-10, it may suppress T-cell production of other cytokines (IFN-γ, TNF-α) and enable systemic spread of virus | 197, 217, 218 |
| TGF-β | Elevated | Immunosuppressive cytokine with pleiotropic effects | 217 |